Riskpilot← Back to searchSign inGet full accessSimatech AB
ABBankruptOrg 5569825572Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20140 employees
Revenue 2022
SEK 1,3M
+74% vs 2021
EBITDA margin
-16.3%
-5175% vs 2021
Equity ratio
-620.0%
Financial strength
Net profit 2022
SEK -270K
-335% vs 2021
| Revenue | SEK 1,3M | +74% |
| EBITDA | SEK -211K | -5175% |
| Net profit | SEK -270K | -335% |
| Total assets | SEK 70K | -76% |
| Equity | SEK -434K | -163% |
| Employees | 0 | — |
Legal name
Simatech AB
Org number
5569825572
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 september 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom data, IT och elektronikingenjör. Bolaget ska även bedriva verksamhet inom export och import av sjukvård, hälsovård och friskvårdsprodukter och därmed förenlig verksamhet. Bolaget ska också bedriva verksamhet inom uthyrning och leasing av bilar.
Address
Email
martin.silvlund@simatech.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | — | 547 | 413 | 745 | 1 296 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 0 | 48 | −641 | −4 | −211 |
| Depreciation & amort. | — | −0 | −10 | −44 | −44 |
| EBIT | 0 | 48 | −651 | −48 | −255 |
| Net financials | — | −1 | −10 | −14 | −14 |
| Profit before tax | 0 | 47 | −660 | −62 | −270 |
| Tax | — | −0 | −0 | −0 | −0 |
| Net profit | — | 47 | −660 | −62 | −270 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | — | 209 | 339 | 297 | 70 |
| Equity | — | 40 | −147 | −165 | −434 |
| Long-term debt | — | 0 | 290 | 230 | 170 |
| Short-term debt | — | 169 | 196 | 231 | 334 |
| Total debt | — | 169 | 486 | 461 | 504 |
EBITDA margin
-16.3%
This company
15.8%
Market median
-203% vs market
20182022
Equity ratio
-620.0%
This company
38.2%
Market median
-1723% vs market
20182022
Return on equity
-27000000.0%
This company
18.4%
Market median
-146739230% vs market
20182022
Net profit margin
-20.8%
This company
8.1%
Market median
-357% vs market
20182022
Asset turnover
18.51×
This company
1.12×
Market median
+1553% vs market
20182022
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
SS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Simatech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Sahebi | Deputy Chief Executive Officer | 0 companies |
| Martin Silvlund | Chief Executive Officer | 0 companies |
| Andreas Leonidas Botis | Deputy Board Member | 0 companies |
| Gustaf Nicklas Norgren | Board of Directors | 0 companies |
| Nebez Kassem | Deputy Board Member | 0 companies |